Kong Z and colleagues present evidence suggesting that DAB2IP-deficient prostate cancer cells that have metastasized show greater clonogenic survival when treated with ionizing radiation than control cells expressing normal levels of DAB2IP. The gene discussed is DAB2IP; the disease is prostate carcinoma.